יום שישי, ד׳ תמוז תשפ״וFriday, June 19, 2026
Follow Us
Sections
E-Edition
By Aryeh Savir, Tazpit News Agency
The first three patients who recovered as part of the clinical study demonstrated a rapid clinical benefit and have been discharged home from the hospital.
Two months ago, Hadassah Medical Center started collecting plasma rich with antibodies from recovered Coronavirus patients, with the aim of producing a treatment for severely ill patients.
Kitov Pharmaceuticals accounted it plans to apply for listing on the NASDAQ exchange, joining Israel-based Teva and Kamada that are traded on Wall Street. Kitov is hoping for approval from the U.S. Food and Drug Administration (FDA) after its Phase III clinical trial of a combination drug for the treatment of hypertension and pain relief. […]
